​

Funding Round

Series C - Abogen Biosciences

Series C - Abogen Biosciences

Investment Firm

Overview

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.

Announced Date

Nov 29, 2021

Funding Type

Series C

Highlights

Location

Asia

Social

Investor Lead

5Y Capital

5Y Capital

5Y Capital is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorKeyuan Industry Fund
Participant InvestorJinyi Capital
Participant InvestorChimera Investment
Participant InvestorIMO Ventures
Participant Investor5Y Capital

Round Details and Background

Abogen Biosciences raised $300000000 on 2021-11-29 in Series C

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 19, 2021
Series C - Abogen Biosciences
21-1000.0M
Nov 29, 2021
Series C - Abogen Biosciences
12-300.0M
Jul 01, 2020
Seed Round - Abogen Biosciences
1-undefined
Jan 01, 2019
Angel Round - Abogen Biosciences
1-undefined

Recent Activity

There is no recent news or activity for this profile.